Publications by authors named "Kevin Rockich"

Claim this Profile
E
Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib.
Yan-Ou Yang, Yunlan Fang, Phillip Wang, Xiang Liu, Jay Getsy, Kevin Rockich

Br J Clin Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical cardiac safety of zilurgisertib, an activin receptor-like kinase-2 (ALK2) inhibitor, in healthy participants.
Yan-Ou Yang, Hong Yang, Xing Liu, Xiaohua Gong, Jay Getsy, Kevin Rockich

Clin Pharmacol Drug Dev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Itraconazole or Rifampin on Zilurgisertib Pharmacokinetics When Administered Orally in Healthy Participants.
Yan-Ou Yang, Xiaohua Gong, Phillip Wang, Xiang Liu, Jay Getsy, Kevin Rockich

Clin Pharmacol Drug Dev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers.
Tomoki Koishikawa, Kaku Fujiwara, Kunal Taskar, Maciej J Zamek-Gliszczynski, Kenta Yoshida, Kevin Rockich

Clin Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults.
Yan-Ou Yang, Xiaohua Gong, Jay Getsy, Phillip Wang, Xiang Liu, Kevin Rockich

Eur J Drug Metab Pharmacokinet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions.
Tatsuki Mochizuki, Maciej J Zamek-Gliszczynski, Kenta Yoshida, Jialin Mao, Kunal Taskar, Kevin Rockich

Clin Pharmacol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugs.
Tatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, Kenta Yoshida, Yurong Lai, Kevin Rockich

Clin Transl Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the pharmacokinetics of pemigatinib in patients with impaired hepatic or renal function.
Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang

Br J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of drug-drug interactions of pemigatinib in healthy participants.
Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang

Eur J Clin Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Evaluation of drug‑drug interactions of pemigatinib in healthy participants.
Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang

Eur J Clin Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hepatic Impairment on the Pharmacokinetics of Itacitinib.
April M Barbour, Kevin Rockich, Evan Cimino, Gongfu Zhou, Caterina Leonetti-Whalen

J Clin Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label Study to Assess the Effect of Itraconazole and Rifampin on Parsaclisib Pharmacokinetics When Administered Orally in Healthy Participants.
Jia Li, Kevin Rockich, Brad Yuska, Gongfu Zhou, Noam Epstein

J Clin Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
Marc A Riedl, William R Lumry, H Henry Li, Aleena Banerji, Jonathan A Bernstein, Kevin Rockich

Allergy Asthma Proc· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Gudmundur Johannsson, Hans Lennernäs, Claudio Marelli, Kevin Rockich, Stanko Skrtic

Eur J Endocrinol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I safety and pharmacokinetic study of the PI3K/mTOR inhibitor SAR245409 (XL765) in combination with erlotinib in patients with advanced solid tumors.
Pasi A Jänne, Roger B Cohen, A Douglas Laird, Sandrine Macé, Jeffrey A Engelman, Kevin Rockich

J Thorac Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre- or post-treatment with the mitochondrial uncoupler 2,4-dinitrophenol attenuates striatal quinolinate lesions.
William F Maragos, Kevin T Rockich, Jesse J Dean, Kristie L Young

Brain Res· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis